Posted by linkadge on January 31, 2010, at 17:29:32
In reply to Re: Is Suicide Ever A Viable Option?, posted by linkadge on January 31, 2010, at 17:13:39
Also, a high number of patients with depression recieve augmentation with atypical antipsychotics.
There is good reason to believe that cleaner augmentation with selective 5-ht2a blockers like eplivanserin would reduce complications associated with long term atypical antipsychotic exposure.
Then all of a sudden, boom, eplivanserin is not approvable. Why? Even if it just tested effective as a substitute to atypical augmentation, this would be an ethical advantage.
But no, without good reason we need to continue consuming the diabetogenic drugs, potentially indefinately.
Linkadge
poster:linkadge
thread:935487
URL: http://www.dr-bob.org/babble/20100122/msgs/935528.html